Wolverine Trading, LLC Sage Therapeutics, Inc. Transaction History
Wolverine Trading, LLC
- $96.9 Billion
- Q2 2025
A detailed history of Wolverine Trading, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 18,390 shares of SAGE stock, worth $159,625. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,390
Previous 11,635
58.06%
Holding current value
$159,625
Previous $92,000
81.52%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding SAGE
# of Institutions
216Shares Held
50.1MCall Options Held
790KPut Options Held
440K-
Madison Avenue Partners, LP New York, NY6.08MShares$52.7 Million5.93% of portfolio
-
Black Rock Inc. New York, NY5.22MShares$45.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$28.3 Million0.0% of portfolio
-
Hudson Bay Capital Management LP Greenwich, CT1.95MShares$16.9 Million0.07% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.92MShares$16.6 Million0.01% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $516M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...